Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback